Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05973825 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immuno-virological Evaluation of Persons Living With HIV (PLWH)

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Jul 12, 2027 → Dec 31, 2027
See other at-risk trials from University Hospital, Ghent

Record History

See every version on ClinicalTrials.gov ↗

  1. Recruitment opened Show 6 more changesShow less
    • Start date changed from estimate of Sep 1, 2024 to Feb 13, 2025
    • Primary completion pushed from Jul 12, 2027 to Dec 31, 2027
    • Study completion moved earlier from Jul 12, 2029 to Dec 31, 2027
    • Eligibility criteria shortened, about 14 words
    • Study description expanded, about 6 words
    • Site details revised
  2. Primary completion date: Jul 12, 2026 to Jul 12, 2027
    • Start date: Jun 1, 2024 to Sep 1, 2024
    v6
  3. Start date: Apr 1, 2024 to Jun 1, 2024v5
  4. Start date: Jan 1, 2024 to Apr 1, 2024v4
  5. Start date: Nov 13, 2023 to Jan 1, 2024v3
  6. Start date: Sep 13, 2023 to Nov 13, 2023v2
  7. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a dual arm (arm 1 and arm 2) multi-centric non-randomized (prospective) study. Two new multicentric cohorts will be set up in 4 Belgian HIV reference centers (UZ Gent, UZ Brussel, University Hospital Liege and St. Pierre Hospital Brussels): cohort 1 will comprise PLWH in whom ART was initiated during acute HIV infection minimum 3 years ago but no more than 10 years ago (short-term ART cohort); cohort 2 will comprise PLWH on ART since \>20 years (long-term ART cohort). Participants will be included based on suppressed viremia and uninterrupted ART since initiation. Participants will undergo one blood sampling and one leukapheresis. In and exclusion criteria are described below.
Trial Details
NCT Number NCT05973825
Lead Sponsor University Hospital, Ghent
Collaborators: Vrije Universiteit Brussel, Centre Hospitalier Universitaire Saint Pierre, Centre Hospitalier Universitaire de Liege, Universitair Ziekenhuis Brussel, Université Libre de Bruxelles, KU Leuven
Conditions
(from sponsor)		 HIV-1-infection, HIV Seropositivity
Related terms HIV Seropositivity
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov